MADRIGAL PHARMACEUTICALS, INC. Public Float
MADRIGAL PHARMACEUTICALS, INC. (MDGL) had Public Float of $5.60 billion as of 2025-06-30, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-19
- 2025-06-30: Entity Public Float $5.60B.
- 2024-06-30: Entity Public Float $5.10B.
- 2023-06-30: Entity Public Float $3.16B.
- 2022-06-30: Entity Public Float $984.86M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $5.60B 10-K · filed 2026-02-19 |
| 2024-06-30 | $5.10B 10-K · filed 2025-02-26 |
| 2023-06-30 | $3.16B 10-K · filed 2024-02-28 |
| 2022-06-30 | $984.86M 10-K/A · filed 2023-03-03 |
| 2021-06-30 | $819.35M 10-K · filed 2022-02-24 |
| 2020-06-30 | $1.13B 10-K · filed 2021-02-25 |
| 2019-06-28 | $884.20M 10-K · filed 2020-02-26 |
| 2018-06-29 | $2.32B 10-K · filed 2019-02-27 |
| 2017-06-30 | $84.56M 10-K · filed 2018-03-13 |
| 2016-06-30 | $29.12M 10-K · filed 2017-03-31 |
| 2015-06-30 | $205.26M 10-K · filed 2016-03-15 |
| 2014-06-30 | $275.00M 10-K · filed 2015-03-12 |
| 2013-06-30 | $195.20M 10-K · filed 2014-03-11 |
| 2012-06-30 | $206.42M 10-K · filed 2013-03-14 |
| 2011-06-30 | $144.50M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |